Vaccine Manufacturing Insights

The discussion reveals a significant shift in vaccine manufacturing processes aimed at scaling production for billions. Key insights include the lack of animal testing and preclinical studies despite the regulatory body's awareness of the new methods. Detailed analytical comparisons between the original and new mRNA vaccines were requested, highlighting the complexities involved in ensuring safety and efficacy.